SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-004429
Filing Date
2022-02-09
Accepted
2022-02-09 17:01:07
Documents
74
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vktx-10k_20211231.htm   iXBRL 10-K 2882940
2 EX-4.5 vktx-ex45_7.htm EX-4.5 66131
3 EX-21.1 vktx-ex211_33.htm EX-21.1 1562
4 EX-23.1 vktx-ex231_9.htm EX-23.1 2792
5 EX-31.1 vktx-ex311_10.htm EX-31.1 20331
6 EX-31.2 vktx-ex312_8.htm EX-31.2 20308
7 EX-32.1 vktx-ex321_6.htm EX-32.1 12671
8 GRAPHIC g3br4zisb1ro000001.jpg GRAPHIC 31647
  Complete submission text file 0001564590-22-004429.txt   10573554

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA vktx-20211231.xsd EX-101.SCH 66973
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20211231_cal.xml EX-101.CAL 57194
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20211231_def.xml EX-101.DEF 217536
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20211231_lab.xml EX-101.LAB 507179
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20211231_pre.xml EX-101.PRE 401824
68 EXTRACTED XBRL INSTANCE DOCUMENT vktx-10k_20211231_htm.xml XML 2032897
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37355 | Film No.: 22608030
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences